233 related articles for article (PubMed ID: 20554591)
21. Steroid therapy in chronic obstructive pulmonary disease.
OBrien A; Ward NS
Med Health R I; 2002 Feb; 85(2):52-5. PubMed ID: 11881166
[TBL] [Abstract][Full Text] [Related]
22. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
23. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease.
Lindenauer PK; Pekow PS; Lahti MC; Lee Y; Benjamin EM; Rothberg MB
JAMA; 2010 Jun; 303(23):2359-67. PubMed ID: 20551406
[TBL] [Abstract][Full Text] [Related]
24. What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease?
López-Campos JL; Calero Acuña C
Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):43-51. PubMed ID: 23551023
[TBL] [Abstract][Full Text] [Related]
25. Effect of corticosteroids on exacerbations of asthma and chronic obstructive pulmonary disease.
Calverley PM
Proc Am Thorac Soc; 2004; 1(3):161-6. PubMed ID: 16113429
[TBL] [Abstract][Full Text] [Related]
26. Systemic corticosteroid for COPD exacerbations, whether the higher dose is better? A meta-analysis of randomized controlled trials.
Cheng T; Gong Y; Guo Y; Cheng Q; Zhou M; Shi G; Wan H
Clin Respir J; 2013 Oct; 7(4):305-18. PubMed ID: 23072733
[TBL] [Abstract][Full Text] [Related]
27. Is there a role for systemic corticosteroids in the management of stable chronic obstructive pulmonary disease?
Wood-Baker R
Am J Respir Med; 2003; 2(6):451-8. PubMed ID: 14719984
[TBL] [Abstract][Full Text] [Related]
28. Personalized Variable vs Fixed-Dose Systemic Corticosteroid Therapy in Hospitalized Patients With Acute Exacerbations of COPD: A Prospective, Multicenter, Randomized, Open-Label Clinical Trial.
Li L; Zhao N; Ma X; Sun F; He B; Qin Z; Wu K; Wang X; Zhao Q; Zhang S; Nie N; Luo D; Sun B; Shen Y; He Y; Wen F; Zheng J; Jones P; Cao G
Chest; 2021 Nov; 160(5):1660-1669. PubMed ID: 34023318
[TBL] [Abstract][Full Text] [Related]
29. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis.
Fan VS; Bryson CL; Curtis JR; Fihn SD; Bridevaux PO; McDonell MB; Au DH
Am J Respir Crit Care Med; 2003 Dec; 168(12):1488-94. PubMed ID: 14525798
[TBL] [Abstract][Full Text] [Related]
30. Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a clinical benefit?
Man SF; Sin DD
Drugs; 2005; 65(5):579-91. PubMed ID: 15748094
[TBL] [Abstract][Full Text] [Related]
31. [Corticosteroids for treatment of patients with chronic obstructive pulmonary disease].
Nishimura K
Nihon Rinsho; 2003 Dec; 61(12):2181-6. PubMed ID: 14674330
[TBL] [Abstract][Full Text] [Related]
32. Use of inhaled corticosteroids in COPD: improving efficacy.
Yang IA; Shaw JG; Goddard JR; Clarke MS; Reid DW
Expert Rev Respir Med; 2016; 10(3):339-50. PubMed ID: 26855301
[TBL] [Abstract][Full Text] [Related]
33. Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction.
Martinez FJ; Vestbo J; Anderson JA; Brook RD; Celli BR; Cowans NJ; Crim C; Dransfield M; Kilbride S; Yates J; Newby DE; Niewoehner D; Calverley PM;
Am J Respir Crit Care Med; 2017 Apr; 195(7):881-888. PubMed ID: 27767328
[TBL] [Abstract][Full Text] [Related]
34. [The effects of inhaled steroids withdrawal in COPD].
Jebrak G; Honore I; Serrier P; Dumoulin J; Terrioux P; Soyez F; Maurer C; Mangiapan G; Febvre M; Couderc LJ; Braun JM; Chinet T
Rev Mal Respir; 2017 Oct; 34(8):820-833. PubMed ID: 28506728
[TBL] [Abstract][Full Text] [Related]
35. Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease.
Nannini L; Cates CJ; Lasserson TJ; Poole P
Cochrane Database Syst Rev; 2004; (3):CD003794. PubMed ID: 15266502
[TBL] [Abstract][Full Text] [Related]
36. Effects of corticosteroids on systemic inflammation in chronic obstructive pulmonary disease.
Man SF; Sin DD
Proc Am Thorac Soc; 2005; 2(1):78-82. PubMed ID: 16113473
[TBL] [Abstract][Full Text] [Related]
37. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial.
van Velzen P; Ter Riet G; Bresser P; Baars JJ; van den Berg BTJ; van den Berg JWK; Brinkman P; Dagelet JWF; Daniels JMA; Groeneveld-Tjiong DRGL; Jonkers RE; van Kan C; Krouwels FH; Pool K; Rudolphus A; Sterk PJ; Prins JM
Lancet Respir Med; 2017 Jun; 5(6):492-499. PubMed ID: 28483402
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two systemic steroid regimens for the treatment of COPD exacerbations.
Ceviker Y; Sayiner A
Pulm Pharmacol Ther; 2014 Apr; 27(2):179-83. PubMed ID: 23518215
[TBL] [Abstract][Full Text] [Related]
39. Incident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids?
Festic E; Scanlon PD
Am J Respir Crit Care Med; 2015 Jan; 191(2):141-8. PubMed ID: 25409118
[TBL] [Abstract][Full Text] [Related]
40. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
